EvidInvest Blog
Investment analysis, valuation guides, and market insights.
The DCF Verdict on AI Datacenter Stocks: Why NVDA, AVGO, and SMCI Valuations Diverge by 1,000%
We ran three valuation methods on NVIDIA, Broadcom, and Super Micro using real historical CAGRs, a normalized growth model, and Wall Street consensus. The outputs differ by up to 1,000%. Here is why — and what it tells you.
Mag 7 Carries Q1 2026 Again — The Concentration Trade Is Back
S&P 500 beat rate hit 84% in Q1 2026. But strip out the Magnificent 7 and index earnings growth drops from +11% to +3.5%. What this means for your diversified portfolio.
How to Read SEC Filings During a Geopolitical Shock
When a Taiwan strait headline drops, most investors panic. We built a supply chain graph from 557 real SEC filing edges to show you exactly which paragraph to read — and which chokepoints actually matter.
AI & Data Center Earnings Season: The $520B Capex Reality Check
Intel surges on a revenue beat, AMD rallies ahead of its report, and NVIDIA looms. We break down the Q1 2026 semiconductor earnings with real data -- what's reported, what's coming, and what the valuations say.
Build a Portfolio Automation Pipeline with AI: Stock Lists, Optimization, and Rebalancing via MCP
Use EvidInvest MCP to create stock lists, run MPT optimization, check valuations, and find rebalance candidates — all through natural language. No spreadsheets, no UI.
Financial MCP Servers Compared: Raw Data vs. Real Analysis
We compared 6 financial MCP servers for Claude. Most just wrap data APIs. Here is what happens when your AI agent gets pre-computed valuations, DCF models, and portfolio optimization instead of raw numbers.
Q1 2026 Earnings Season Kicks Off: Big Bank Scoreboard
Goldman Sachs beats by 7%, Citi profits surge 42%, JPMorgan posts $50B revenue. We break down the numbers, chart the volatility, and show what the valuations say.
We Ran MPT on the Top 100 US Stocks. Here is What We Found.
Sharpe ratio of 2.32. Expected return of 52%. We tested the math behind hedge-fund portfolio optimization on real US stocks — here is what it looks like in practice.
15 Years of MPT: How Portfolio Construction Beat the Market (With Real Data)
We ran Modern Portfolio Theory optimization across 3 different portfolio types — tech, healthcare, and diversified — over 15 years of real data. Here is what the math actually shows.
I Built a Magnificent 7 Dashboard in 10 Minutes Using EvidInvest MCP
Screener websites are dying. Here is how to build a live Mag7 comparison dashboard with 1-year performance, P/E, PEG, and growth metrics using EvidInvest MCP and a few tool calls.
Magnificent 7 in 2026: Which One Is Actually Cheap?
PEG ratios, forward P/E, EV/EBITDA, and analyst upside for all 7. The data shows two clear value plays, two fairly valued, and one in a category of its own.
Is NVDA Overvalued in 2026? A DCF Analysis
NVIDIA's stock has soared on AI demand. We run a DCF to find NVDA's intrinsic value in 2026 — and whether the current price offers a margin of safety.
How EvidInvest's Portfolio Optimizer Works: Markowitz, Max Sharpe, and Real Data
A plain-language explanation of Modern Portfolio Theory, how we implemented it with real price data and covariance shrinkage, and what the optimizer actually tells you — including its honest limitations.
Why Your Stock Score Might Be Lying to You
Stock scoring tools like Simply Wall St apply the same algorithm to banks, SaaS companies, and commodities miners. Here's why that's a problem — and what to look for instead.
What Is DCF Valuation? A Beginner Guide
Learn how Discounted Cash Flow (DCF) analysis works, why investors use it, and how to calculate intrinsic value for any stock.